Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Building the What Comes Next Cohort for BRCA1 and BRCA2 testing: a descriptive analysis.

CMAJ open - 1 Jan 2000

Dossa Fahima, Metcalfe Kelly, Sutradhar Rinku, Little Tari, Eisen Andrea, Chun Kathy, Meschino Wendy S, Velsher Lea, Ellis Jordan Lerner, Baxter Nancy N

Abstract excerpt

BACKGROUND: Our understanding of how testing for and mutations of the BRCA1 and BRCA2 genes affect cancer risk and the use of risk-reduction strategies comes largely from studies of women recruited from specialized genetics clinics. Our aim was to assemble a generalizable cohort of women who underwent BRCA1/BRCA2 testing (the What Comes Next Cohort), irrespective of test result, to enable study of health care...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Ontario

Share to Ovarian Neoplasms

Share to Patient Acceptance of Health Care

Share to Predictive Value of Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 34870614
DOI: 10.9778/cmajo.20200228
PMCID: PMC8741196

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Building the What Comes Next Cohort for BRCA1 and BRCA2 testing: a descriptive analysis.PMID 34870614Read ↗

Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.Semantic proximity Read ↗

Breast and Ovarian Cancer Among Individuals Undergoing BRCA1 and BRCA2 Testing.Semantic proximity Read ↗

Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population.Semantic proximity Read ↗

Genetic testing for BRCA1 and BRCA2 in the Province of Ontario.Semantic proximity Read ↗

Genetic screening for gynecological cancer: where are we heading?Semantic proximity Read ↗

Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort study.Semantic proximity Read ↗

BRCA1/2 testing for genetic susceptibility to cancer after 25 years: A scoping review and a primer on ethical implications.Semantic proximity Read ↗

BRCA awareness and testing experience in the UK Jewish population: a qualitative study.Semantic proximity Read ↗

Uptake of genetic counseling and multi-gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing.Semantic proximity Read ↗

Suboptimal Adherence to Hereditary Cancer Risk Management Guidelines: A Cohort Study of High-Risk Individuals in Newfoundland and Labrador, Canada.Semantic proximity Read ↗

Population-based Genetic Testing for Precision Prevention.Semantic proximity Read ↗

Patient uptake of updated genetic testing following uninformative BRCA1 and BRCA2 results.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.